Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 29:12:797749.
doi: 10.3389/fcimb.2022.797749. eCollection 2022.

Offense and Defense in Granulomatous Inflammation Disease

Affiliations
Review

Offense and Defense in Granulomatous Inflammation Disease

Xinwen Wang et al. Front Cell Infect Microbiol. .

Abstract

Granulomatous inflammation (GI) diseases are a group of chronic inflammation disorders characterized by focal collections of multinucleated giant cells, epithelioid cells and macrophages, with or without necrosis. GI diseases are closely related to microbes, especially virulent intracellular bacterial infections are important factors in the progression of these diseases. They employ a range of strategies to survive the stresses imposed upon them and persist in host cells, becoming the initiator of the fighting. Microbe-host communication is essential to maintain functions of a healthy host, so defense capacity of hosts is another influence factor, which is thought to combine to determine the result of the fighting. With the development of gene research technology, many human genetic loci were identified to be involved in GI diseases susceptibility, providing more insights into and knowledge about GI diseases. The current review aims to provide an update on the most recent progress in the identification and characterization of bacteria in GI diseases in a variety of organ systems and clinical conditions, and examine the invasion and escape mechanisms of pathogens that have been demonstrated in previous studies, we also review the existing data on the predictive factors of the host, mainly on genetic findings. These strategies may improve our understanding of the mechanisms underlying GI diseases, and open new avenues for the study of the associated conditions in the future.

Keywords: bacteria; gene; granulomatous inflammation diseases; immune response; intracellular bacteria; predisposing factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
A journey of GI microbes in the host. Epithelium is the gateway for the introduction of GI microbes inside the host and subsequent progression of GI diseases. Once microbes get through the gateway, the process of phagocytosis is initiated, and macrophages are the first line of defense. In macrophages, invading microbes are engulfed by phagocytosis into phagosomal structures and encounter a complex and dynamic range of host defenses. The recognition of bacterial antigens by a range of pattern recognition receptors expressed by macrophages triggers a signaling cascade leading to the recruitment of a diverse cell type complement including neutrophils, dendritic cells, natural killer cells, T lymphocytes and B lymphocytes.

References

    1. Abe C., Iwai K., Mikami R., Hosoda Y. (1984). Frequent Isolation of Propionibacterium Acnes From Sarcoidosis Lymph Nodes. Zentralbl. Bakteriol. Mikrobiol. Hyg. A. 256, 541–547. doi: 10.1016/s0174-3031(84)80032-3 - DOI - PubMed
    1. Abroug N., Khairallah-Ksiaa I., Kahloun R., Khochtali S., Zaouali S., Khairallah M. (2015). Parinaud's Oculoglandular Syndrome Revealing Subclinical Rickettsia Conorii Infection. Int. Ophthalmol. 35, 717–719. doi: 10.1007/s10792-015-0094-2 - DOI - PubMed
    1. Adams L. A., Moller M., Nebel A., Schreiber S., van der Merwe L., Van Helden P. D., et al. (2011). Polymorphisms in MC3R Promoter and CTSZ 3'UTR Are Associated With Tuberculosis Susceptibility. Eur. J. Hum. Genet. 19, 676–681. doi: 10.1038/ejhg.2011.1 - DOI - PMC - PubMed
    1. Adrianto I., Lin C. P., Hale J. J., Levin A. M., Datta I., Parker R., et al. (2012). Genome-Wide Association Study of African and European Americans Implicates Multiple Shared and Ethnic Specific Loci in Sarcoidosis Susceptibility. PLoS One 7, e43907. doi: 10.1371/journal.pone.0043907 - DOI - PMC - PubMed
    1. Agarwal S. K. (2011). Biologic Agents in Rheumatoid Arthritis: An Update for Managed Care Professionals. J. Manag. Care Pharm. 17, S14–S18. doi: 10.18553/jmcp.2011.17.s9-b.S14 - DOI - PMC - PubMed

Publication types